Source: Annual Congress 2005 - Exercise and gas exchange
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. G. El-gazzar, A. A. Enan, M. Y. Tayel, T. H. Belal, A. M. Abdel-Sadek (Benha, Alexandria, Egypt). Cardio-pulmonary exercise testing in systemic lupus erythematosus patients. Eur Respir J 2005; 26: Suppl. 49, 2280

Member's Comments

No comment yet.

Related content which might interest you: Abnormalities on ventilatory efficiency during graded exercise test in juvenile systemic lupus erythematosus patients Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Lung abnormalities in patients with systemic lupus erythematosus Source: Eur Respir J 2001; 18: Suppl. 33, 225s Year: 2001 Examining pulmonary function measures in patients with systemic lupus erythematosus (SLE) Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases Year: 2020 Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus Source: Eur Respir Rev 2011; 20: 277-286 Year: 2011 The pattern and timing of breathing during graded exercise test in systemic lupus erythematosus Source: Annual Congress 2011 - Exercise assessment in different diseases Year: 2011 Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Lung involvement in systemic lupus erythematosus (SLE) - our own experience Source: Eur Respir J 2002; 20: Suppl. 38, 60s Year: 2002 On diagnostics of pneumonitis in patients with lupus erythematosus (LE) Source: Eur Respir J 2005; 26: Suppl. 49, 31s Year: 2005 Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Pulmonary arterial hypertension and systemic lupus erythematosus Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Sleep-related disturbances in systemic lupus erythematosus Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Effectiveness of ²Korargin² in the therapy of pulmonary arterial hypertension in patients with systemic lupus erythematosus Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease Source: Eur Respir Monogr 2019; 86: 106-123 Year: 2019 A functionally improved case of obstructive impairment caused by systemic lupus erythematosus Source: Breathe, 17 (2) 200288; 10.1183/20734735.0288-2020 Year: 2021 Systemic lupus erythematosus (SLE): Cyto- and chemokines as possible serum markers for pulmonary involvement? Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Shrinking lung syndrome (SLS) associated with systemic lupus erythematosus (SLE): A series of cases in a university hospital. Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 The profile of lung scintigraphy in systemic lupus erythematosus with chronic pulmonary embolism:a cross-section Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 Interstitial lung disease associated with systemic lupus erythematosus : a monocentric study of 23 cases. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021